Flagship Ventures Fund 2007’s Agios Pharmaceuticals AGIO Stock Holding History

Flagship Ventures Fund 2007’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$78.4M	Buy	+1,930,369	New	+$82.5M	82.31%	1

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Flagship Ventures Fund 2007's AGIO Position: Q1 2016 in Review

Flagship Ventures Fund 2007 opened a new position in Agios Pharmaceuticals (AGIO) in Q1 2016: 1,930,369 shares worth $78.4M. The stake represents 82.31% of the portfolio and ranks #1 among its holdings.

157 funds tracked by Wall St. Rank hold AGIO as of Q1 2016.

Flagship Ventures Fund 2007 held 1,930,369 shares of Agios Pharmaceuticals worth $78.4M as of Q1 2016.
Agios Pharmaceuticals was a new Flagship Ventures Fund 2007 position in Q1 2016.
Agios Pharmaceuticals made up 82.31% of Flagship Ventures Fund 2007's portfolio in Q1 2016, its #1 holding.
157 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2016.

Based on Flagship Ventures Fund 2007's 13F filing for Q1 2016, filed 13 May 2016.